Therapix Bio

TRPX NASDAQ
2.380
+0.040
+1.71%
交易中 14:10 08/19 EDT
开盘
2.400
昨收
2.340
最高
2.450
最低
2.370
成交量
4.73万
成交均量(3M)
10.35万
52周最高
9.30
52周最低
2.040
换手率
1.35%
市值
832.35万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Therapix Bio TRPX股票价格,Therapix Bio股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Therapix Biosciences Ltd, formerly Nasvax Ltd, is an Israel-based company active in the pharmaceutical sector. The Company develops improved vaccines and immunotherapeutics. Its products include Anti-CD3 oral immunotherapy, directed toward the treatment of inflammatory and autoimmune diseases; Group-common Pneumococcal Vaccine, based on surface proteins that are highly conserved among pneumococcal strains, hence able to stimulate protective immune responses against pneumococcal strains in general; Alzheimer’s Disease Immunotherapy develops immunotherapeutic products for Alzheimer’s disease; and Adjuvant-Delivery platform, VaxiSome, serves both as a potent adjuvant for stimulating enhanced immune responses via the Th1 and Th2 pathways as well as an efficient delivery system. This liposomal adjuvant delivery system also may be applied to augment the bioactivity of other established adjuvants and cytokines.
展开 >

最近浏览

名称
价格
涨跌幅